e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
V. Bessa, K. Darwiche, B. Bödeker, J. I. Baumbach, U. Sommerwerck, O. Anhenn, L. Freitag (Essen, Germany)
Source:
Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Session:
Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Session type:
Thematic Poster Session
Number:
4289
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Bessa, K. Darwiche, B. Bödeker, J. I. Baumbach, U. Sommerwerck, O. Anhenn, L. Freitag (Essen, Germany). Volatile organic compounds (VOC) in exhaled breath of patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 4289
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Exhaled volatile organic compounds in nonrespiratory diseases
Source: Eur Respir Monogr 2010; 49: 140-151
Year: 2010
Expiratory flow rate and breath hold affect exhaled volatile organic compounds (VOC) in healthy subjects
Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation
Year: 2012
Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Standardization of exhaled volatile organic compounds (VOCs) measurement
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds
Source: Eur Respir J 2005; 26: Suppl. 49, 373s
Year: 2005
Diet and alcohol affect exhaled volatile organic compounds (VOCs)
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Exhaled volatile organic compounds as markers for medication use in asthma
Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019
Year: 2020
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept